| Georgina Uche Obiesie, | |
|
7506 Georgia Ave Nw, Washington, DC 20012-1608 | |
| (202) 291-6973 | |
| Not Available |
| Full Name | Georgina Uche Obiesie |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 7506 Georgia Ave Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356681159 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | LPN1007425 (District Of Columbia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Georgina Uche Obiesie, 10415 Beacon Ridge Dr, Bowie, MD 20721-2944 Ph: (714) 878-9485 | Georgina Uche Obiesie, 7506 Georgia Ave Nw, Washington, DC 20012-1608 Ph: (202) 291-6973 |
News Archive
Wearable technology is raising health concerns worldwide. A recent New York Times article by Nick Bilton is raising important and unanswered questions about the safety of wearable tech, according to the non-profit research group, Environmental Health Trust.
Women at high-risk of cardiovascular disease who took a daily supplement of folic acid and vitamin B6 and B12 for seven years did not have an overall reduced rate of cardiovascular events, despite a significant lowering of homocysteine levels, according to a study in the May 7 issue of JAMA, the Journal of the American Medical Association.
Dr. Alma Guerrero, assistant professor of pediatrics at Mattel Children's Hospital UCLA, has been awarded a $100,000 grant from The Robert Wood Johnson Foundation (RWJF), to research racial and ethnic disparities in dietary behaviors that lead to obesity among California children and examine the family and neighborhood factors associated with these dietary behaviors.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it has initiated a Phase II feasibility trial designed to examine the efficacy and safety of pimavanserin as a treatment for patients with Alzheimer's disease psychosis.
› Verified 9 days ago
Emmanuel Mbu, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2811 Pennsylvania Ave Se, Washington, DC 20020 Phone: 301-379-8449 | |
Stella Segun, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6856 Eastern Ave Nw, Suite 220, Washington, DC 20012 Phone: 202-545-6980 | |
Yolanda Blagrove, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 801 Pennsylvania Ave Se, Washington, DC 20003 Phone: 202-796-0605 | |
Nwaneka Onuaku, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6856 Eastern Ave Nw Ste 320a, Washington, DC 20012 Phone: 202-541-9844 | |
Priscillia N Moghalu, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6856 Eastern Ave Nw, Washington, DC 20012 Phone: 202-541-9844 | |
Jasmine Rhodes, HHA, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 505 Madison St Nw, Washington, DC 20011 Phone: 202-600-6972 | |
Rochelle Fadare, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 7600 Georgia Ave Nw Ste 323, Washington, DC 20012 Phone: 202-723-3060 Fax: 202-723-3065 |